Dehydroxymethylepoxyquinomicin, a Novel Nuclear Factor-κB Inhibitor, Enhances Antitumor Activity of Taxanes in Anaplastic Thyroid Cancer Cells
Zhaowei Meng(Tianjin Medical University General Hospital), Shunichi Yamashita(Fukushima Medical University)
Cited by 37
Related Papers
The Selective Tyrosine Kinase Inhibitor, STI571, Inhibits Growth of Anaplastic Thyroid Cancer Cells
|The Journal of Clinical Endocrinology & Metabolism|2003|82
Biological Features Implies Potential Use of Autologous Adipose-Derived Stem/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy
|International Journal of Molecular Sciences|2019|23
Prolonged cetuximab treatment promotes p27Kip1-mediated G1 arrest and autophagy in head and neck squamous cell carcinoma
|Scientific Reports|2021|20
8th International Workshop on Microbeam Probes of Cellular Radiation Response
|Journal of Radiation Research|2009|2